DIDO1 anticorps (N-Term)
Aperçu rapide pour DIDO1 anticorps (N-Term) (ABIN127222)
Antigène
Voir toutes DIDO1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- The antibody recognizes the 62 kDa Dio-1.
-
Purification
- Protein A affinity purified
-
Immunogène
- Synthetic peptide near the N-terminus of mouse Dio-1.
-
-
-
-
Indications d'application
-
Western Blot: 0.5-4 μg/mL, Jurkat cell lysate and mouse small intestine tissue lysate can beused as positive controls.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.2 mg/mL
-
Buffer
- PBS containing 30 % glycerol, 0.5 % BSA, and 0.01 % thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C/-80 °C
-
Stockage commentaire
- Store the antibody undiluted at -20 °C or for long term storage (in aliquots) at -70 °C.
-
-
- DIDO1 (Death Inducer-Obliterator 1 (DIDO1))
-
Autre désignation
- DIDO1
-
Sujet
- Apoptosis plays an important role in many cellular processes. Dio-1 (Death Inducer-O bliterator-1), a putative transcription factor, has been indicated to function in the onset of apoptosis. Dio-1 expression is upregulated when an apoptosis is detected. It translocates to the nucleus, and activates apoptosis during limb development. Dio-1 expression can be suppressed by caspase inhibitors and Bcl-2 expression.Synonyms: C20orf158, DATF1, Death-inducer obliterator 1, KIAA0333
-
ID gène
- 11083
-
NCBI Accession
- NP_001180298
-
UniProt
- Q9BTC0
-
Pathways
- Hormone Activity
Antigène
-